๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chromosome 10 allelic loss in malignant melanoma

โœ Scribed by Koichi Isshiki; David E. Elder; Dupont Guerry; Dr. Alban J. Linnenbach


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
602 KB
Volume
8
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

โœฆ Synopsis


The involvement of tumor suppressor genes in the progression of melanoma has been suggested by the frequent deletion of specific regions of the genome in melanoma. In this study, a panel of I 8 surgically removed melanomas from I 5 patients was analyzed for loss of heterozygosity (LOH) at I0 polymorphic loci on chromosome 10. LOH was observed in 7 (50%) of I4 informative patients. LOH data suggested that melanomas from 5 patients had lost entire copies of chromosome 10, and that melanomas from 2 patients had lost copies of I Oq. In contrast, LOH was not observed on chromosome 15, 20, or 2 I. These results are consistent with previous cytogenetic observations and provide indirect evidence that there is a tumor suppressor gene on the long arm of chromosome 10 which is relevant to melanoma development. Genes Chrom Cancer 8:/78-184 (1993).


๐Ÿ“œ SIMILAR VOLUMES


Loss of chromosome 3 alleles and multipl
โœ Barnhard Horsthemke; Gabriele Prescher; Reinhard Becher; Norbert Bornfeld ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 486 KB

lnstitut fur Humangenetik (B.H.), lnnere Klinik und Poliklinik (Tumorfonchung) (G.P., R.B.), and Zentrum fur Augenheilkunde (N.B.). Univenitatsklinikum Essen, Federal Republic of Germany Uveal melanoma is the most frequent primary intraocular tumor. The etiology is unknown. Using neutral DNA polymo

Simple tandem repeat allelic deletions c
โœ Graeme J. Walker; Jane M. Palmer; Marilyn K. Walters; Derek J. Nancarrow; Peter ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 526 KB

## Abstract Karyotypic analysis, loss of somatic heterozygosity, microcell fusion and cDNA transfection studies have provided compelling evidence that at least one tumour suppressor gene for melanoma resides on chromosome 6. In an attempt to further define the regions to which these putative suppre

Frequent allelic loss on chromosome 9 in
โœ Choong Tsek Liew; Hiu Ming Li; Kwok Wai Lo; Chon Kar Leow; Wan Yee Lau; Lin Yee ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 137 KB ๐Ÿ‘ 2 views

Hepatocellular carcinoma (HCC) is a common malignancy worldwide and highly associated with chronic virus-B or -C infection and cirrhosis. Molecular studies have shown high frequency of loss of heterozygosity (LOH) in some specific chromosome regions, but LOH on chromosome 9 in HCC has not been thoro

Allelic loss on chromosome 6Q in primary
โœ Vasantha Srikantan; Isabell A. Sesterhenn; Leland Davis; Gerald R. Hankins; Fran ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 183 KB ๐Ÿ‘ 2 views

Molecular genetic analyses of human prostate cancer (CaP) has revealed frequent loss of specific chromosome regions suggesting the presence of putative tumor suppressor gene(s) (TSG) on these chromosome loci whose inactivation may play a role in prostate tumorigenesis. To understand the role of 6q a

Allelic losses in human chromosome II in
โœ Masayoshi Lizuka; Yuki Sugiyama; Masahiko Shiraishi; Carol Jones; Dr. Takao Seki ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 524 KB

The relatively frequent loss of heterozygosity at loci on the short arm of chromosome I I in human lung cancers has suggested the presence of a putative tumor suppressor gene. For location of the gene, a fine deletion map of human chromosome I I was constructed by analysis of DNAs from 79 lung cance

Characterization of chromosome 1 abnorma
โœ Damian Smedley; Sanjiv Sidhar; Sandra Birdsall; Dorothy Bennett; Meenhard Herlyn ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 239 KB

Chromosome 1 abnormalities are the most commonly detected aberrations in many cancers including malignant melanomas. Specific breakpoints are reported for malignant melanomas throughout the chromosome but especially at 1p36 and at several sites throughout 1p22-q21. In addition, partial deletions and